Doctors specialising in menopause have expressed relief following Pharmac's recent u-turn.
Pharmac has announced it'll fund both the Estradot and Mylan brands of hormone replacement patches from December, after public consultation.
It follows backlash in response to its decision to switch suppliers
Menodoctor Clinical Director Dr Linda Dear says this is the news they needed to hear.
She says it's good to have these options because one may work better for some women than the other - and added losing Estradot recently was devastating.
LISTEN ABOVE
See omnystudio.com/listener for privacy information.
Heather du Plessis-Allan Drive